Prophylactic antibiotics for cardiac pacemaker implantation. A prospective trail.
A prospective trial was conducted to assess the value of prophylactic antibiotic treatment in preventing postoperative infection of permanent transvenous pacemaker systems. Four hundred and thirty-one patients were randomly allocated to treatment (234) or no-treatment (197) groups. Treated patients received systemic benzylpenicillin and flucloxacillin just before operation and one and six hours afterwards. Nine primary generator pocket infections occurred without evidence of wound dehiscence or skin erosion. Seven infections were in untreated patients and two in treated patients. Antibiotic prophylaxis diminishes the risk of infection after pacemaker implantations.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000517:prevention & control*; D004338:Drug Combinations; D005436:Floxacillin / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D010400:Penicillin G / Q000627:therapeutic use; D011292:Premedication; D011446:Prospective Studies; D013997:Time Factors
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005436:Floxacillin; D010400:Penicillin G